Immuno-oncology is the new frontier in cancer treatment. Using the body’s own immune system to treat cancer, new therapies are producing impressive survival benefits, with reduced side effects. Of these therapies, immune checkpoint inhibitors are showing particular promise. This infographic is a snapshot of the PD-1/PD-L1 market.
Jump to a slide with the slide dots.
Two clients were co-developing a product and needed to understand the patient journey in two areas of oncology.
Read moreHear how market research can deliver the insights needed to successfully launch in this increasingly complex and competitive environment.
Read moreThe report is an excerpt of our ethnographic research of oncology patients in the UK with head and neck and gastric cancer.
Read moreRapport is our monthly newsletter where we share our latest expertise and experience.